17-82083991-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_004104.5(FASN):c.5082C>T(p.Arg1694Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000351 in 1,539,424 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
FASN
NM_004104.5 synonymous
NM_004104.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.685
Publications
0 publications found
Genes affected
FASN (HGNC:3594): (fatty acid synthase) The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008]
FASN Gene-Disease associations (from GenCC):
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 17-82083991-G-A is Benign according to our data. Variant chr17-82083991-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 531170.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.685 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FASN | ENST00000306749.4 | c.5082C>T | p.Arg1694Arg | synonymous_variant | Exon 29 of 43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
| FASN | ENST00000634990.1 | c.5076C>T | p.Arg1692Arg | synonymous_variant | Exon 29 of 43 | 5 | ENSP00000488964.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152218Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
9
AN:
152218
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000723 AC: 10AN: 138272 AF XY: 0.0000804 show subpopulations
GnomAD2 exomes
AF:
AC:
10
AN:
138272
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000324 AC: 45AN: 1387088Hom.: 0 Cov.: 41 AF XY: 0.0000278 AC XY: 19AN XY: 684068 show subpopulations
GnomAD4 exome
AF:
AC:
45
AN:
1387088
Hom.:
Cov.:
41
AF XY:
AC XY:
19
AN XY:
684068
show subpopulations
African (AFR)
AF:
AC:
4
AN:
31500
American (AMR)
AF:
AC:
4
AN:
35582
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25082
East Asian (EAS)
AF:
AC:
4
AN:
35668
South Asian (SAS)
AF:
AC:
2
AN:
79108
European-Finnish (FIN)
AF:
AC:
0
AN:
39306
Middle Eastern (MID)
AF:
AC:
2
AN:
5576
European-Non Finnish (NFE)
AF:
AC:
27
AN:
1077482
Other (OTH)
AF:
AC:
2
AN:
57784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152336Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
9
AN:
152336
Hom.:
Cov.:
34
AF XY:
AC XY:
5
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41572
American (AMR)
AF:
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68014
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Epileptic encephalopathy Benign:1
May 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.